These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4346780)

  • 1. [Pressor effect of angiotensin II and norepinephrine in patients with hypertension treated with alpha methyldopa].
    Imbs JL; Spach MO; Velly J; Desaulles E
    Therapie; 1972; 27(5):937-46. PubMed ID: 4346780
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in renal inactivation of angiotensin II in rats with hereditary spontaneous hypertension.
    Altman J; Ducrot H
    Pathol Biol (Paris); 1977 Jun; 25(6):383-7. PubMed ID: 335344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the reactivity of skin arterioles in hypertension under the influence of histamine].
    Hotovy E; Losonci A
    Z Gesamte Inn Med; 1968 Mar; 23(6):182-5. PubMed ID: 4302436
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in renal function and electrolyte transport after acute decrease of blood pressure induced by a decarboxylase inhibitor (alpha-methyldopa)].
    Koçak N; Kalkay N; Ozdoğan E
    Turk Tip Cemiy Mecm; 1967; 33(11):671-80. PubMed ID: 5598385
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of alpha methyldopa and spironolactone on angiotensin sensitivity in man].
    Káldor A; Kállay K; Sebestyén K; Alexits K
    Orv Hetil; 1972 Jan; 113(1):23-4. PubMed ID: 4333395
    [No Abstract]   [Full Text] [Related]  

  • 6. Sodium and fluid balance during hypotensive response to alpha-methyldopa.
    Birkenhäger WH; de Leeuw PW; Geerling J; Statius van Eps LW
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():43-9. PubMed ID: 354828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the vasopressor effect and inactivation of angiotensin in essential and renal as well as experimental hypertension].
    Wernze H; Hosoda S; Schölkens B
    Arch Klin Med; 1968; 214(3):286-305. PubMed ID: 4300861
    [No Abstract]   [Full Text] [Related]  

  • 8. Pressor factors and cardiovascular pressor responsiveness after short-term antihypertensive therapy with the calcium antagonist nifedipine alone or combined with a diuretic.
    Marone C; Luisoli S; Bomio F; Beretta-Piccoli C; Bianchetti MG; Weidmann P
    J Hypertens Suppl; 1984 Dec; 2(3):S449-52. PubMed ID: 6599697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary salt intake, blood pressure and the kidney in hypertensive patients with non-insulin dependent diabetes mellitus.
    Campese VM; Wurgaft A; Safa M; Bianchi S
    J Nephrol; 1998; 11(6):289-95. PubMed ID: 10048494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of the dose and hypertension in realizing the renal effect of angiotensin].
    Branchevskiĭ LL
    Biull Eksp Biol Med; 1973 May; 75(5):53-5. PubMed ID: 4360361
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hypertension with cyclothiazide (Doburil) and chlorthalidone (Hygroton)].
    Enk B; Persson I
    Ugeskr Laeger; 1969 Oct; 131(42):1791-3. PubMed ID: 5376952
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of angiotensin and nonadrenaline in pressor and non pressor doses on the urinary secretion of sodium in uncompensated cirrhotic patients].
    Andrade U; Cipullo JP; Ajzen H; Sustovich DR; Gelman A; Stella SR; Ramos OL
    Rev Assoc Med Bras; 1967 Jun; 13(6):199-206. PubMed ID: 4302349
    [No Abstract]   [Full Text] [Related]  

  • 13. Propranolol versus chlorthalidone--a prospective therapeutic trial in children with chronic hypertension.
    Bachmann H
    Helv Paediatr Acta; 1984 Mar; 39(1):55-61. PubMed ID: 6373679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Self-control of the blood pressure in hypertension therapy].
    Enger E
    Tidsskr Nor Laegeforen; 1972 Feb; 92(4):257-63. PubMed ID: 5016488
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin I- and II- and norepinephrine-mediated pressor responses in an ancient holostean fish, the bowfin (Amia calva).
    Butler DG; Oudit GY; Cadinouche MZ
    Gen Comp Endocrinol; 1995 Jun; 98(3):289-302. PubMed ID: 7628688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Controllable hypertension therapy with Tadip].
    Schütz E
    Med Klin; 1971 Jan; 66(4):121-6. PubMed ID: 5546736
    [No Abstract]   [Full Text] [Related]  

  • 17. Potentiation by alpha-methyldopa of pressor responses to angiotensin.
    Privitera PJ; Mohammed S
    Proc Soc Exp Biol Med; 1970 Apr; 133(4):1358-60. PubMed ID: 4314860
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of chronic pretreatment with alpha-methyldopa and reserpine upon the sensitivity of the vascular system to noradrenaline and hypertensin].
    Formanek K; Lindner A; Selzer H
    Med Pharmacol Exp Int J Exp Med; 1966; 15(1):45-54. PubMed ID: 4288184
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased cardiovascular reactivity in renal infarction hypertension.
    Basso N; de la Riva IJ
    Acta Physiol Lat Am; 1974; 24(2):109-18. PubMed ID: 4375405
    [No Abstract]   [Full Text] [Related]  

  • 20. Release of renin by human kidney slices, in vitro effect of angiotensin II, norepinephrine and aldosterone.
    Rosset E; Veyrat R
    Rev Eur Etud Clin Biol; 1971 Oct; 16(8):792-4. PubMed ID: 4331508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.